JP2005506037A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506037A5
JP2005506037A5 JP2002546579A JP2002546579A JP2005506037A5 JP 2005506037 A5 JP2005506037 A5 JP 2005506037A5 JP 2002546579 A JP2002546579 A JP 2002546579A JP 2002546579 A JP2002546579 A JP 2002546579A JP 2005506037 A5 JP2005506037 A5 JP 2005506037A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002546579A
Other versions
JP2005506037A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/045336 external-priority patent/WO2002044210A2/en
Publication of JP2005506037A publication Critical patent/JP2005506037A/ja
Publication of JP2005506037A5 publication Critical patent/JP2005506037A5/ja
Pending legal-status Critical Current

Links

JP2002546579A 2000-12-01 2001-11-30 脊髄および脳で発現される新規なヒトイオンチャンネルをコードする新規なヒト核酸分子およびポリペプチド Pending JP2005506037A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25058700P 2000-12-01 2000-12-01
PCT/US2001/045336 WO2002044210A2 (en) 2000-12-01 2001-11-30 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain

Publications (2)

Publication Number Publication Date
JP2005506037A JP2005506037A (ja) 2005-03-03
JP2005506037A5 true JP2005506037A5 (ja) 2005-05-26

Family

ID=22948356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002546579A Pending JP2005506037A (ja) 2000-12-01 2001-11-30 脊髄および脳で発現される新規なヒトイオンチャンネルをコードする新規なヒト核酸分子およびポリペプチド

Country Status (8)

Country Link
US (1) US20030027164A1 (ja)
EP (1) EP1379652A2 (ja)
JP (1) JP2005506037A (ja)
AU (1) AU2002232456A1 (ja)
CA (1) CA2436941A1 (ja)
IL (1) IL155613A0 (ja)
MX (1) MXPA03004781A (ja)
WO (1) WO2002044210A2 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020156253A1 (en) * 2000-06-26 2002-10-24 Curtis Rory A.J. 48000 and 52920, novel human calcium channels and uses thereof
GB0128161D0 (en) * 2001-11-23 2002-01-16 Merck Sharp & Dohme Receptor protein
EP1473303B1 (en) * 2002-01-18 2010-02-24 Takeda Pharmaceutical Company Limited Sodium dependent bile acid transporter and use thereof
WO2003087158A2 (en) * 2002-04-16 2003-10-23 Bayer Healthcare Ag Regulation of human transient receptor potential channel
AU2003232513A1 (en) * 2002-04-25 2003-11-10 Rheinische Friedrich-Wilhelms- Universitaet Bonn Pain receptor gene and protein
AU2003283594A1 (en) * 2002-11-18 2004-06-15 Merck Sharp And Dohme Limited Vanilloid receptor-2 ligands for treating anxiety or depression
CN101233132A (zh) * 2005-05-09 2008-07-30 海德拉生物科学公司 调节trpv3功能的化合物
US8916550B2 (en) * 2005-05-09 2014-12-23 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
US7893260B2 (en) * 2005-11-04 2011-02-22 Hydra Biosciences, Inc. Substituted quinazolin-4-one compounds for antagonizing TRPV3 function
WO2008033564A1 (en) * 2006-09-15 2008-03-20 Hydra Biosciences Inc. Compounds for modulating trpv3 function
WO2008140750A1 (en) * 2007-05-10 2008-11-20 Hydra Biosciences Inc. Compounds for modulating trpv3 function
US8392124B2 (en) * 2008-11-14 2013-03-05 The Invention Science Fund I, Llc Food content detector
WO2010124200A2 (en) 2009-04-23 2010-10-28 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for cancer
US9314005B2 (en) 2009-07-01 2016-04-19 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for severe combined immunodeficiency (SCID)
EP3485889B1 (en) 2011-12-16 2023-09-06 Poseida Therapeutics, Inc. Trpc4 modulators for use in the treatment or prevention of pain
EP3597223A1 (en) * 2018-07-17 2020-01-22 Centre National De La Recherche Scientifique Peptides for use as cell-penetrating peptides
BR112022014933A2 (pt) 2020-01-29 2022-09-20 Kamari Pharma Ltd Compostos e composições para uso no tratamento de distúrbios de pele

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US219806A (en) * 1879-09-23 Improvement in measuring devices for creating wantage
US9537A (en) * 1853-01-11 Arrangement op screw-ctttting dies
GB9713484D0 (en) * 1997-06-27 1997-09-03 Smithkline Beecham Plc Neuroprotective vanilloid compounds
AU742391B2 (en) * 1997-08-20 2002-01-03 Regents Of The University Of California, The Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
JP2002500885A (ja) * 1998-01-27 2002-01-15 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ヒトバニロイド受容体相同体
WO2002012340A2 (en) * 2000-08-03 2002-02-14 Incyte Genomics, Inc. Transporters and ion channels
GB2372993A (en) * 2000-11-03 2002-09-11 Smithkline Beecham Plc Vanilloid Receptor 6

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ja)
BE2022C547I2 (ja)
BE2017C057I2 (ja)
BE2017C051I2 (ja)
BE2017C032I2 (ja)
BE2016C051I2 (ja)
BE2015C077I2 (ja)
BE2015C046I2 (ja)
BE2014C052I2 (ja)
BE2014C036I2 (ja)
BE2014C026I2 (ja)
BE2014C004I2 (ja)
BE2014C006I2 (ja)
BE2017C050I2 (ja)
BE2011C034I2 (ja)
BE2007C047I2 (ja)
AU2002307149A8 (ja)
JP2002107274A5 (ja)
JP2002200078A5 (ja)
BRPI0209186B1 (ja)
BE2014C008I2 (ja)
BRPI0204884A2 (ja)
BE2016C021I2 (ja)
JP2002230557A5 (ja)
JP2005506037A5 (ja)